tirzepatide drug information (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus Adverse events associated with tirzepatide:

Tirzepatide - sold under the names Mounjaro and Zepbound - is likely better than semaglutide - sold under the names Ozempic and Wegovy - for weight loss, say international researchers funded by the company that makes tirzepatide

Timothy Garvey, professor of medicine at the University of Alabama at Birmingham

A recent meta-analysis showed that ALCAR supplementation as a standalone intervention significantly alleviated depressive symptoms compared to placebo or no intervention (Veronese et al., 2018)

2. Licorice Extract: Contains compounds that help brighten the skin and inhibit melanin production

Michael Weintraub, MDs Post New Trial Results STEP-HFpEF DM published in NEJM today Semaglutide improved heart failure symptoms and physical limitations in patients with obesity, HFpEF and Type 2 Diabetes 6.4% weight over placebo CRP 6 min walk distance These results are consistent with findings of a prior trial of semaglutide in HFpEF and obesity without type 2 diabetes

This is not a medication where we are guessing about side effects based on small samples